BOSTON--(BUSINESS WIRE)--The DNA Repair Company (DNAR), an emerging company focused on personalized approaches to cancer treatment, announced today the expansion of its management team with the appointments of Brian E. Ward, Ph.D. as executive vice president and Stella Quan, Ph.D. as senior director of product development. Dr. Ward most recently served as senior vice president for Genomic Health, Inc. Dr. Quan joins the company from bioMerieux Inc., where she was director of immunoassay development.
